Jeffrey R Sachs
Overview
Explore the profile of Jeffrey R Sachs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hughes R, Lack C, Sachs J, Hiatt K, Smith S, Steber C, et al.
Radiol Imaging Cancer
. 2025 Feb;
7(2):e240127.
PMID: 39918409
Purpose To develop a practical, easily implementable risk stratification model based on preoperative contrast-enhanced CT (CECT) nodal features to predict the probability of pathologic extranodal extension (pENE) in patients with...
2.
Dudasova J, Valenta Z, Sachs J
NPJ Vaccines
. 2024 Nov;
9(1):214.
PMID: 39528514
Understanding potential differences in vaccine-induced protection between demographic subgroups is key for vaccine development. Vaccine efficacy evaluation across these subgroups in phase 2b or 3 clinical trials presents challenges due...
3.
Cardenas K, Goyal A, Dietzen M, Sachs J, Lipford M, Gorris M, et al.
Radiographics
. 2024 Aug;
44(8):e240129.
PMID: 39088360
- Update articles supplement or update information found in full-length articles previously published in . These updates, written by at least one author of the previous article, provide a brief...
4.
Dudasova J, Valenta Z, Sachs J
BMC Med Res Methodol
. 2024 Apr;
24(1):101.
PMID: 38689224
Background: Vaccine efficacy (VE) assessed in a randomized controlled clinical trial can be affected by demographic, clinical, and other subject-specific characteristics evaluated as baseline covariates. Understanding the effect of covariates...
5.
Ryman J, Sachs J, Banniettis N, Weiss T, Ahsman M, Yee K, et al.
Expert Rev Vaccines
. 2024 Mar;
23(1):467-473.
PMID: 38546743
Background: Next generation, higher valency pneumococcal conjugate vaccines (PCVs) are assessed and licensed by comparing the immune response across serotypes shared with the PCVs that are standard of care for...
6.
Ryman J, Sachs J, Yee K, Banniettis N, Weaver J, Weiss T
Expert Rev Vaccines
. 2023 Dec;
23(1):60-68.
PMID: 38073483
Background: Next-generation, higher-valency pneumococcal conjugate vaccines (PCVs), 15-valent PCV V114 and 20-valent PCV (PCV20), have been assessed by comparing their immune responses across serotypes shared with the 13-valent PCV (PCV13)....
7.
Schoen J, Burdette J, West T, Geer C, Lipford M, Sachs J
AJR Am J Roentgenol
. 2023 Nov;
222(1):e2330189.
PMID: 37937836
CT scanners' net scan state (i.e., image acquisition period) represents a potential target for energy savings through protocol adjustments. However, gauging CT energy savings is difficult without installing costly energy...
8.
Nussbaum J, Cao X, Railkar R, Sachs J, Spellman D, Luk J, et al.
Vaccine
. 2023 Sep;
41(44):6488-6501.
PMID: 37777449
Human respiratory syncytial virus (RSV) causes a substantial proportion of respiratory tract infections worldwide. Although RSV reinfections occur throughout life, older adults, particularly those with underlying comorbidities, are at risk...
9.
Rosenbloom D, Dudasova J, Davis C, Railkar R, Mehrotra N, Sachs J
Vaccines (Basel)
. 2023 Sep;
11(9).
PMID: 37766177
In vaccine efficacy trials, inaccurate counting of infection cases leads to systematic under-estimation-or "dilution"-of vaccine efficacy. In particular, if a sufficient fraction of observed cases are false positives, apparent efficacy...
10.
Sachs J, Nahmias J, Hiatt K, Bomar J, West T, Bunch P, et al.
Diagnostics (Basel)
. 2022 Nov;
12(11).
PMID: 36428915
There is a paucity of radiologic literature regarding age-related cataract, and little is known about any differences in the imaging appearance of the natural crystalline lens on computed tomography (CT)...